STOCKHOLM, Aug 5 (Reuters) – Danish drugmaker Novo Nordisk said on Wednesday it had won a preliminary injunction against Ceban Ziekenhuisfarmacie B.V. from a district court in the Netherlands in a patent infringement case involving a compounded semaglutide nasal spray.
(Reporting by Anna Ringstrom, editing by Elviira Luoma)
Comments